本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 7月股商强势上涨，股市方面，上证指数单月涨幅达3.74%，站上3600点（8月最新已站上3780点），深证成指涨幅为5.20%，创业板指上涨 8.14%；商品市场方面，南华商品指数月度上涨3.80%，工业品指数上涨4.86%，黑色指数涨幅达8.52%。 如此行情也点燃了投资者信心，私募证券基金产品迎来备案高峰，私募排排网数据显示，7月完成备案的私募证券基金产品数量创出近27个月以 来新高，且备案产品以股票策略、多资产策略、期货及衍生品策略为主。 实际上，当前现有的私募产品同样以这三大策略为主，私募排排网数据显示，截至2025年7月底，以符合排名规则的私募产品数量计共有4425 只， 股票策略、期货及衍生品策略、多资产策略产品数量居前 ，分别为2737只、617只、602只，三大策略产品合计3956只， 占私募产品总数 接近 9成！ 私募排排网数据显示，截至2025年7月底， 符合排名规则的股票策略产品在 3只及以上且有业绩展示的头部私募 合计61家，旗下股票策略产品 共552只，产品规模合计约为875.38亿元。 今年来旗下股票策略产品收益均值前 ...

Group 1 - The core viewpoint of the articles highlights the outstanding performance of private equity funds in the A-share market, with an average return of 11.94% for 11,880 private securities products as of July, 86.97% of which achieved positive returns [1] - Stock strategies have shown particularly strong performance, with 7,760 stock strategy products averaging a return of 14.5%, leading among five major strategies, and 88.2% of these products achieving positive returns [1][2] - Top private equity firms have outperformed the industry average, with 55 billion-level private equity firms averaging a return of 16.6%, and 98.18% of them achieving positive returns [1] Group 2 - Multi-asset strategies follow closely behind stock strategies, with 1,364 multi-asset strategy products averaging a return of 9.59%, and 86.66% of these products achieving positive returns [2] - Combination funds have shown stable performance, with 405 combination funds averaging a return of 8.57%, and 92.10% of these products achieving positive returns [2] - In the bond strategy sector, 1,076 bond strategy products have averaged a return of 5.16%, with 91.54% achieving positive returns [3] Group 3 - The outlook for the market is optimistic, supported by reduced global trade uncertainties and the effectiveness of China's economic structural adjustments, with a focus on sectors like technology, innovative pharmaceuticals, and non-bank financials [3] - The company maintains a high position in its portfolio, particularly in sectors such as overseas AI, domestic computing power, and new consumption [3]

Group 1 - The private securities product registration market is experiencing unprecedented activity, with 1,298 products registered in July, a month-on-month increase of 18%, marking the highest level in nearly 27 months. This reflects a significant recovery in market confidence and a sustained demand for private product allocation [1] - The total number of registered products for the year has reached 6,759, representing a year-on-year increase of over 60%, indicating a clear recovery trend in the private issuance market [1] Group 2 - Quantitative private products have been particularly prominent in this registration wave, with 620 quantitative products registered in July, accounting for 47.77% of the total registered products for the month, and a month-on-month growth of nearly 20% [3] - Among the 13 private firms that registered more than 10 products in July, 11 were quantitative firms, with the top ten spots entirely occupied by quantitative institutions. Wide德 Private Fund led with 31 registered products, followed by Mingcong Investment with 26 [3] - Stock quantitative strategies dominate the quantitative product category, with 478 stock strategy quantitative products registered in July, making up 77.10% of the total quantitative products for the month, and a month-on-month increase of 26.79% [3] Group 3 - Stock strategies continue to play a leading role in private product registrations, with 887 stock strategy products registered in July, accounting for 68.34% of the total registered products, and a month-on-month growth of 24.58% [4] - Multi-asset strategies are emerging as a significant force, with 162 products registered in July, representing 12.48% of the total, and a month-on-month increase of 5.88% [4] - Futures and derivatives strategies, bond strategies, and combination fund strategies also show steady growth, with 125, 48, and 46 products registered respectively, indicating a diversification in investment options for investors [4] Group 4 - A total of 676 private institutions completed product registrations in July, including 48 billion-level private funds and 36 funds with 50 to 100 billion in scale, demonstrating active participation across different scales of private institutions [4]

Core Viewpoint - The article discusses the emergence of private equity firms engaging in creative projects, specifically the production of a short drama centered around futures trading, highlighting the challenges and uncertainties in the futures investment landscape [1] Group 1: Short Drama Production - Three private equity firms, Waying Investment, Shanhai Fund, and Shenhan Capital, have produced a short drama titled "Rebirth in the Millennium: My Revenge Path through Futures" [1] - The drama features a billionaire private equity boss who faces significant losses due to market volatility and personal tragedy, ultimately leading to a second chance in the year 2000 [1] Group 2: Performance of Private Equity Products - As of July 25, 2025, there are 603 futures and derivatives strategy products with a total scale of approximately 34.33 billion, with an average return of 8.73% this year [3] - Among these, 339 quantitative CTA products have an average return of 8.31%, while 156 subjective CTA products have an average return of 12.15% [3] Group 3: Top Performing Products - The top three futures and derivatives strategy products for the year are led by Fuhua Zixin's product, with a return of ***% [9] - In the category of private equity firms with a scale below 5 billion, the top three products are from Fuhua Zixin, Jingsheng Investment, and Ruixin Investment [10] Group 4: Recent Performance Trends - Over the past year, 573 products have shown an average return of 20.66%, with quantitative CTA products averaging 19.07% and subjective CTA products averaging 28.76% [9] - The leading products in this category are managed by Xuming Investment and Fuhua Zixin [10] Group 5: Long-Term Performance - Over the past three years, 345 products have an average return of 61.65%, with quantitative CTA products averaging 30.18% and subjective CTA products averaging 74.70% [14] - The top three products in this category are from Fuying Investment, Xuming Investment, and Ruixin Tiansuan [15]

Core Viewpoint - The A-share market's strong rebound has significantly boosted investor confidence, leading to explosive growth in the issuance of new private equity products [1][4]. Group 1: Private Equity Product Issuance - In July, the number of registered private equity securities products reached 1,298, a month-on-month increase of 18%, marking a 27-month high [2][3]. - The total number of registered private equity securities products this year has surged over 60% year-on-year, with quantitative strategies performing particularly well and attracting substantial capital inflows [2][4]. - The cumulative number of registered private equity securities products in the first half of the year reached 5,576, with a total registered scale of 184.13 billion yuan [4]. Group 2: Strategy Distribution - Stock strategies dominated the July registrations, accounting for 887 products, or 68.34% of the total, with a month-on-month growth of 24.58% [5][6]. - Multi-asset strategies and futures/derivatives strategies also showed steady growth, with 162 and 125 products registered in July, respectively [9]. Group 3: Market Dynamics - The strong performance of quantitative strategies has led to a rapid increase in management scale for many quantitative private equity firms, with the top ten registered products all belonging to billion-yuan quantitative institutions [2][6]. - The market's rebound and the outstanding performance of quantitative investments have driven significant capital inflows, reflecting a strong demand for asset allocation [4][7].

Core Viewpoint - Since the "9.24 market" last year, the A-share market has shown a structural slow bull trend, with private equity products focusing on stock strategies achieving strong performance in the first half of this year and over the past year. However, over a longer time frame of three to five years, futures and derivatives strategies have shown stronger performance, with significant increases in commodities like gold and lithium carbonate [2][3]. Summary by Category Private Equity Strategy Performance - As of June 30, 2025, there are 593 futures and derivatives strategy products that meet ranking criteria, with average returns of 39.11% over three years and 97.41% over five years, outperforming other strategies [2][3]. - The average returns for various strategies in the first half of the year and over different time frames are as follows: - Stock Strategy: 12.36% (H1), 36.36% (1 year), 35.48% (3 years), 74.97% (5 years) - Futures and Derivatives Strategy: 5.04% (H1), 18.12% (1 year), 39.43% (3 years), 98.23% (5 years) - Multi-Asset Strategy: 8.20% (H1), 25.76% (1 year), 37.34% (3 years), 95.98% (5 years) - Bond Strategy: 5.54% (H1), 13.01% (1 year), 35.14% (3 years), 82.64% (5 years) - Combination Fund: 6.72% (H1), 20.70% (1 year), 15.06% (3 years), 34.10% (5 years) - Overall Average: 10.08% (H1), 30.13% (1 year), 35.81% (3 years), 80.06% (5 years) [3]. Top Performing Private Equity Firms - Among firms with over 20 billion in assets, the top three in futures and derivatives strategy returns over three years are: 1. Junfu Investment 2. Junchen Asset 3. Loshu Investment - The average returns for these firms are not disclosed due to regulatory requirements [4][5]. - Junfu Investment focuses on a diverse range of asset classes, including commodity strategies and various index enhancements, with eight qualifying products showing returns above a certain threshold [6][9]. Mid-Sized Private Equity Firms - For firms with 5-20 billion in assets, the top three in futures and derivatives strategy returns over three years are: 1. Guanzhi Fund 2. Zhemeng Investment 3. Mingrui (Beijing) Private Equity - The average returns for these firms are also not disclosed [10][12]. Small Private Equity Firms - Among firms with 0-5 billion in assets, the top three in futures and derivatives strategy returns over three years are: 1. Fuying Investment 2. Qihe New Asset Management 3. Mufeng Investment - The average returns for these firms exceed a certain threshold, with Fuying Investment's top product showing significant returns [15][16].

Market Performance - In the first half of 2025, the A-share market showed strong resilience amid a complex domestic and international environment, with the Shanghai Composite Index rising by 2.75% and the North Stock 50 Index leading with a remarkable increase of 39.45% [1] - The total trading volume in the A-share market reached 162.68 trillion yuan, significantly higher than the 101 trillion yuan recorded in the same period of 2024, indicating a rapid increase in market activity [1] Private Equity Fund Performance - Among the 495 billion private equity products with reported performance, the average return for the first half of the year was 10.18%, with an excess return of 8.84% [2] - There was a notable divergence in performance among different strategies, with quantitative long strategies achieving an average return of 18.84%, while subjective long strategies only averaged 3.32% [1][2] Strategy Breakdown Quantitative Long Strategies - A total of 194 quantitative long products were reported, with the top performers identified based on excess returns [3] - The leading product was from Longqi Technology, with significant returns attributed to favorable market conditions and a strong belief in the potential for excess returns in the Chinese market [7][8] Subjective Long Strategies - There were 165 subjective long products, with the average return being only 3.32%, highlighting a stark contrast with quantitative strategies [4][11] - The top-performing product in this category focused on medical innovation, benefiting from strong market trends in the healthcare sector [11] Market Neutral Strategies - The average return for 35 market-neutral products was reported at 6.62%, with notable performers including Mingcong Investment and Weiguan Asset [12][14] Multi-Asset Strategies - The average return for 46 multi-asset strategies was 6.45%, with several products achieving significant returns [15][17] Futures and Derivatives Strategies - The average return for 25 futures and derivatives products was 3.82%, with the top product from Xinhong Tianhe showing strong performance [19][22]

Core Viewpoint - The A-share market demonstrated strong resilience in the first half of 2025, with a "volatile upward and structurally differentiated" trend, as evidenced by the performance of various indices and a significant increase in trading volume [2] Market Performance - The Shanghai Composite Index rose by 2.75%, the Shenzhen Component Index increased by 0.48%, and the ChiNext Index gained 0.53%. The North Stock 50 Index, representing small-cap stocks, saw the highest increase of 39.45% [2] - Total trading volume in the A-share market reached 162.68 trillion yuan, significantly higher than the 101 trillion yuan recorded in the same period of 2024, indicating a rapid increase in market activity [2] Private Equity Fund Performance - In the first half of 2025, 495 products from billion-yuan private equity firms reported performance, with an average return of 10.18% and an excess return of 8.84% [2][3] - There was a notable divergence in performance among different strategies, with quantitative long strategies achieving an average return of 18.84%, while subjective long strategies only averaged 3.32% [2][3] Strategy Breakdown Quantitative Long Strategies - A total of 194 quantitative long products were analyzed, with the top performers based on excess returns [4] - The top 10 quantitative long products included firms such as Longqi Technology and Stable Investment, with Longqi Technology's product leading the list [5][8] Subjective Long Strategies - There were 165 subjective long products, with an average return of 3.32%, indicating a significant performance gap compared to quantitative strategies [8] - The top performers in this category included Harmony One Asset and Evolutionary Asset, with a focus on sectors like medical innovation [12][9] Market Neutral Strategies - 35 market-neutral products were evaluated, with the top 10 showing an average return of ***% [13] - Notable firms in this category included Mingyuan Investment and Micro博易 [16] Multi-Asset Strategies - 46 multi-asset products were reviewed, achieving an average return of 6.45% [17] - The leading product in this category was from Blackwing Asset, which demonstrated strong performance [19] Futures and Derivatives Strategies - 25 products in the futures and derivatives category were analyzed, with an average return of 3.82% [20] - The top product was from Xinhong Tianhe, which achieved significant excess returns [23]

Core Insights - The private equity securities fund industry has shown strong performance in the first five months of the year, with an average return of 4.34% across 12,843 funds, and 74.81% of these funds achieving positive returns [1] Group 1: Performance by Strategy - Equity strategies led the market with an average return of 4.81%, with 73.5% of the 8,487 equity funds reporting positive returns [1] - Multi-asset strategies followed with an average return of 4.14%, while futures and derivatives strategies and combination funds had returns of 3.19% and 3.09% respectively [1] - Bond strategies lagged with an average return of 2.42%, indicating a performance gradient among different strategies in the current market environment [1] Group 2: Quantitative Strategies - The strong performance of quantitative strategies is attributed to a favorable market environment characterized by a small-cap growth style [1] - Within equity strategies, quantitative long strategies performed exceptionally well, with an average return of 8.46% and 86.62% of the 1,480 funds achieving positive returns [1] - Market-neutral strategies also performed well, with an average return of 5.00% and a positive return rate of 91.18% [1] Group 3: Futures and Derivatives Strategies - In the futures and derivatives strategies, quantitative CTA strategies had an average return of 3.38%, slightly outperforming subjective CTA strategies at 3.37% [2] - The proportion of funds with positive returns for quantitative CTA strategies was 70.36%, compared to 65.19% for subjective CTA strategies [2] - Other derivatives strategies and options strategies had average returns of 2.45% and 2.41% respectively [2] Group 4: Market Outlook - Leading private equity institutions express optimism for the market, with indications that the A-share market has completed a "bottoming" phase [2] - A prominent private equity firm believes that the A-share market is entering a historic opportunity for asset value reassessment, anticipating significant upward movement [2] - Another firm notes that A-share valuations are currently low, with ample potential funding and a clear policy stance to stabilize the economy and stock market, leading to growing investor confidence [2]

Group 1 - The private equity securities fund market is showing a strong recovery trend, with 4,361 funds registered in the first five months, a year-on-year increase of 45.03% [1] - In May alone, 870 funds were registered, representing a significant year-on-year growth of 77.19%, indicating a new wave of development in the private equity industry [1] Group 2 - Quantitative private equity funds are leading the market recovery, with 1,930 funds registered in the first five months, accounting for 44.26% of the total registered private equity securities funds [3] - Among the 66 private equity institutions with at least 10 registered products, 40 are large institutions, with 31 being quantitative private equity firms, highlighting the strong growth of leading quantitative firms [3] - The majority of quantitative private equity products focus on stock strategies, with 1,339 products registered, making up 69.38% of the total quantitative products [3] Group 3 - Stock strategies remain dominant, with 2,749 stock strategy products registered, representing 63.04% of the total 4,361 private equity securities funds [4] - Multi-asset strategies and futures and derivatives strategies rank second and third, with 646 and 510 products registered, accounting for 14.81% and 11.69% respectively [4] - The distribution of strategies reflects an increasing demand for diversified investment options among investors [4] Group 4 - There are 1,558 private equity fund managers with registered products, with 1,177 small firms managing under 1 billion yuan and registering 2,062 products [4] - Medium-sized firms managing between 1 billion and 5 billion yuan have 259 firms with 914 registered products, while large firms managing over 5 billion yuan have 122 firms with 1,385 registered products [4]